GO:0010604 positive regulation of macromolecule metabolic process: Regulatory Hub, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010604 describes any process that increases the frequency, rate or extent of the chemical reactions and pathways involving macromolecules, such as nucleic acids, proteins, and polysaccharides.
• This term is a parent node that encompasses positive regulation of transcription, translation, DNA replication, and other macromolecule metabolic pathways.
• Key positive regulators include mTOR, which controls ependymal cell differentiation by targeting the alternative cell cycle and centrosomal proteins.
• Dysregulation of macromolecule metabolic processes is linked to diverse pathologies, including sarcopenia, atherosclerosis, and diabetic nephropathy.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential to dissect the causal roles of genes within this GO term.
• Studying this process requires integrated methods such as RNA-seq, Ribo-seq, proteomics, and metabolic analysis to capture dynamic changes.
Description
The Gene Ontology (GO) term GO:0010604, positive regulation of macromolecule metabolic process, defines any biological process that increases the frequency, rate, or extent of the chemical reactions and pathways involving macromolecules. Macromolecules are large molecules such as proteins, nucleic acids, and polysaccharides, built from repeating units. This term is a high-level regulatory node that integrates signals from diverse pathways to control the synthesis, modification, and degradation of these essential biomolecules. Understanding this process is fundamental because it governs cell growth, proliferation, differentiation, and adaptation to stress. In porcine oocytes, for example, markers of transcription and macromolecule metabolic process regulation are critical for successful in vitro maturation. Similarly, in C. elegans, metabolic analysis of sarcopenic muscle has identified positive modulators of longevity and healthspan that act through macromolecule metabolic pathways. Thus, GO:0010604 represents a central hub that coordinates cellular metabolism with physiological outcomes.
positive regulation of macromolecule metabolic process At A Glance
| GO ID | GO:0010604 |
|---|---|
| GO term | positive regulation of macromolecule metabolic process |
| Ontology | biological_process |
| Synonym | none |
| Major function | Upregulation of metabolic pathways for macromolecules (e.g., proteins, nucleic acids) |
| Parent term | regulation of macromolecule metabolic process (GO:0060255) |
| Child terms | positive regulation of transcription, positive regulation of translation, positive regulation of DNA replication, etc. |
| Related diseases | Sarcopenia, atherosclerosis, diabetic nephropathy, cancer |
| Key regulators | mTOR, transcription factors, signaling kinases |
What Is GO:0010604?
GO:0010604, positive regulation of macromolecule metabolic process, is defined as any process that increases the frequency, rate or extent of the chemical reactions and pathways involving macromolecules, which are molecules of high relative molecular mass essentially comprising multiple repetition of units derived from molecules of low relative molecular mass. In simpler terms, it is the set of mechanisms that boost the building, breakdown, and modification of large molecules like proteins and DNA.
Why Is positive regulation of macromolecule metabolic process Important in Cell Biology?
GO:0010604 is critically important because it governs the rate-limiting steps of macromolecule metabolism, which are essential for cell growth, division, and survival. Dysregulation of this process contributes to a wide range of diseases, including metabolic disorders, cancer, and age-related decline. For instance, in diabetic nephropathy, altered macromolecule metabolism in kidney cells leads to pathological matrix accumulation. In atherosclerosis, matricellular proteins modulate macromolecule metabolic processes in the vessel wall. Therefore, understanding the positive regulation of macromolecule metabolism provides insights into disease mechanisms and identifies potential therapeutic targets.
• Controls protein synthesis and degradation, impacting muscle mass and function in sarcopenia.
• Regulates gene expression programs that drive cell differentiation, as shown for mTOR in ependymal cells.
• Modulates extracellular matrix turnover in atherosclerosis, influencing plaque stability.
• Plays a role in oocyte maturation, affecting fertility and embryonic development.
• Is hijacked in cancer to support uncontrolled proliferation and survival.
• Contributes to the pathogenesis of diabetic nephropathy through dysregulated matrix protein metabolism.
• Integrates nutrient and stress signals via mTOR and other kinases.
• Serves as a target for longevity-promoting interventions, as evidenced in C. elegans.
• Involves allosteric regulation of key enzymes, a concept relevant to drug design.
• Autophagy, a macromolecule degradation pathway, is positively regulated by AMBRA1 during development.
What Happens During positive regulation of macromolecule metabolic process?
Initiation of transcriptional programs
In simple terms: The cell starts making more RNA from DNA.
Positive regulation often begins with the activation of transcription factors that bind to promoters and enhancers, increasing the transcription of genes encoding macromolecules. In porcine oocytes, markers for regulation of transcription and macromolecule metabolic process are upregulated during in vitro maturation, indicating active transcriptional programs. This step is critical for producing the mRNA templates needed for protein synthesis.
Translational upregulation
In simple terms: The cell increases protein production from existing mRNA.
Following transcription, positive regulation can enhance translation efficiency. mTOR, a key kinase, promotes translation by phosphorylating components of the translational machinery. In ependymal cells, mTOR controls differentiation by targeting the alternative cell cycle and centrosomal proteins, which are involved in macromolecule metabolism. This ensures adequate protein supply for cellular functions.
Post-translational modifications and folding
In simple terms: New proteins are modified and folded into their active shapes.
After synthesis, proteins undergo post-translational modifications (e.g., phosphorylation, glycosylation) and folding, which are part of macromolecule metabolic processes. Positive regulation can increase the activity of enzymes that catalyze these modifications. For example, allosteric regulation of enzymes, as discussed by Morea et al., modulates metabolic flux through macromolecule pathways.
Degradation and recycling
In simple terms: The cell breaks down old or damaged macromolecules to recycle building blocks.
Positive regulation also extends to degradative pathways such as autophagy and proteasomal degradation. AMBRA1-regulated autophagy is essential for vertebrate development, and its positive regulation ensures timely clearance of macromolecules. This balance between synthesis and degradation is crucial for metabolic homeostasis.
Integration with metabolic signaling
In simple terms: The cell senses nutrients and energy to adjust macromolecule metabolism.
Signaling pathways like mTOR integrate nutrient availability with macromolecule metabolism. In sarcopenic muscle, metabolic analysis identified positive modulators of longevity and healthspan, highlighting the role of metabolic signaling in regulating macromolecule processes. This integration allows cells to adapt to changing conditions.
Key Genes Involved in GO:0010604 positive regulation of macromolecule metabolic process
The following genes and proteins are key players in the positive regulation of macromolecule metabolic process, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MTOR | Central kinase that promotes translation, ribosome biogenesis, and autophagy inhibition | Controls ependymal cell differentiation and is a target for longevity research |
| AMBRA1 | Regulates autophagy, a macromolecule degradation pathway | Essential for vertebrate development and implicated in cancer |
| S100A proteins | Calcium-binding proteins involved in inflammation and macromolecule metabolism | Spatial distribution in glioblastoma microenvironment |
| Matricellular proteins (e.g., thrombospondins, tenascins) | Modulate cell-matrix interactions and macromolecule turnover | Implicated in atherosclerosis development |
| Transcription factors (e.g., MYC, HIF1A) | Drive transcriptional programs for macromolecule synthesis | Markers in porcine oocyte maturation |
| Ribosomal proteins | Components of the translation machinery | Dysregulated in ribosomopathies and cancer |
| Proteasome subunits | Mediate protein degradation | Linked to muscle wasting and neurodegeneration |
| Autophagy-related genes (ATGs) | Control autophagosome formation | Regulated by AMBRA1 in development |
| Insulin/IGF-1 signaling components | Activate mTOR and promote anabolism | Involved in diabetic nephropathy |
| Sirtuins | NAD+-dependent deacetylases that regulate metabolism | Associated with longevity and sarcopenia |
| AMPK | Energy sensor that inhibits mTOR and activates catabolism | Potential target for metabolic diseases |
| eIF4E | Cap-binding protein in translation initiation | Regulated by mTOR to enhance protein synthesis |
| 4E-BP1 | Inhibitor of eIF4E, phosphorylated by mTOR | Biomarker of mTOR activity |
| S6K1 | Ribosomal protein S6 kinase, promotes translation | Downstream of mTOR in cell growth |
| HSP70 | Molecular chaperone for protein folding | Protects against proteotoxic stress |
| Ubiquitin ligases | Attach ubiquitin to target proteins for degradation | Regulate macromolecule turnover |
How Is positive regulation of macromolecule metabolic process Regulated?
The positive regulation of macromolecule metabolic process is orchestrated by a complex network of signaling pathways. Central to this regulation is the mechanistic target of rapamycin (mTOR), which integrates nutrient, energy, and growth factor signals to promote anabolic processes such as protein synthesis and inhibit catabolic processes like autophagy. mTOR achieves this by phosphorylating downstream effectors including S6K1 and 4E-BP1, thereby enhancing translation initiation. Conversely, AMP-activated protein kinase (AMPK) acts as an energy sensor that inhibits mTOR when cellular energy is low, shifting metabolism toward catabolism. Additionally, allosteric regulation of key enzymes provides rapid, fine-tuned control of metabolic flux. In developmental contexts, AMBRA1 regulates autophagy, a macromolecule degradation pathway, to ensure proper vertebrate development. These regulatory layers ensure that macromolecule metabolism is appropriately matched to cellular demands and environmental conditions.
positive regulation of macromolecule metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MTOR | Ependymal cell differentiation, cancer, metabolic disorders | Knockout and point mutation models in cell lines and organoids |
| AMBRA1 | Vertebrate development, autophagy-related diseases | Knockout and knock-in mouse models |
| S100A proteins | Glioblastoma microenvironment | Overexpression and knockout in glioma cell lines |
| Matricellular proteins | Atherosclerosis | Knockout and overexpression in vascular smooth muscle cells |
| Insulin/IGF-1 signaling | Diabetic nephropathy | Knockout and point mutation in podocytes and mesangial cells |
Sarcopenia and Age-Related Muscle Loss
Sarcopenia, the age-related loss of muscle mass and function, is associated with dysregulated macromolecule metabolism. Metabolic analysis of sarcopenic muscle in C. elegans identified positive modulators of longevity and healthspan, suggesting that enhancing macromolecule metabolic processes can mitigate muscle decline. Targeting these pathways may offer therapeutic strategies for sarcopenia.
Atherosclerosis and Vascular Disease
Atherosclerosis involves the accumulation of lipids and extracellular matrix in arterial walls, driven in part by altered macromolecule metabolism. Matricellular proteins, such as thrombospondins and tenascins, modulate cell-matrix interactions and are implicated in atherosclerosis development. Positive regulation of macromolecule metabolic processes in vascular cells can influence plaque progression and stability.
Diabetic Nephropathy
Diabetic nephropathy is a leading cause of chronic kidney disease, characterized by excessive deposition of extracellular matrix proteins in the glomerulus. The pathogenesis involves dysregulated macromolecule metabolism, including increased synthesis and decreased degradation of matrix components. Understanding the positive regulation of these processes may reveal targets for therapeutic intervention.
Cancer and Glioblastoma
Cancer cells often exhibit enhanced macromolecule metabolism to support rapid growth. In glioblastoma, S100A proteins show a spatial distribution associated with the inflammatory microenvironment, indicating a role in tumor progression. Targeting positive regulators of macromolecule metabolism could disrupt cancer cell anabolism.
From positive regulation of macromolecule metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate macromolecule metabolism? | CRISPR knockout (loss-of-function) followed by metabolic assays |
| Does a specific point mutation in gene X alter its regulatory activity? | CRISPR point mutation (e.g., kinase-dead) knock-in |
| How does tagging gene X affect its localization and interactions? | CRISPR knock-in of fluorescent or epitope tags |
| Does overexpression of gene X enhance macromolecule synthesis? | CRISPR overexpression (e.g., CRISPRa) or cDNA overexpression |
| Which genes are essential for positive regulation in a genome-wide context? | CRISPR library screening (KO or activation) with metabolic readouts |
| What are the transcriptomic and proteomic changes upon gene X modulation? | RNA-seq, Ribo-seq, and proteomics in edited cells |
How to Study the positive regulation of macromolecule metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | mRNA abundance | Transcriptional upregulation of metabolic genes |
| Ribo-seq | Active translation | Translational efficiency of macromolecule synthesis |
| Proteomics | Protein abundance and modifications | Global changes in protein metabolism |
| Metabolomics | Small molecule metabolites | Metabolic flux and pathway activity |
| Fluorescence microscopy | Protein localization and dynamics | Visualizing macromolecule assembly |
| Western blot | Specific protein levels | Validation of candidate regulators |
| CRISPR screening | Gene function at scale | Identifying positive regulators of metabolism |
| Co-immunoprecipitation | Protein-protein interactions | Mapping regulatory complexes |
Transcriptomic and Translational Profiling
RNA sequencing (RNA-seq) measures changes in mRNA levels, providing a snapshot of transcriptional regulation. Ribo-seq (ribosome profiling) goes further by capturing ribosome-protected mRNA fragments, revealing which transcripts are actively translated. These methods are powerful for studying positive regulation of macromolecule metabolic processes, as they can identify genes and pathways whose expression is upregulated.
Proteomic and Metabolomic Analysis
Mass spectrometry-based proteomics quantifies protein abundance and post-translational modifications, offering a direct readout of macromolecule metabolism. Metabolomics measures small molecule intermediates, which can indicate flux through metabolic pathways. In sarcopenic muscle, metabolic analysis identified positive modulators of longevity, demonstrating the value of these approaches.
Imaging and Reporter Assays
Fluorescence microscopy with reporter constructs (e.g., GFP-tagged proteins) allows visualization of macromolecule synthesis and localization in live cells. For example, imaging of S100A proteins revealed spatial distribution in glioblastoma microenvironments. Such techniques help link regulatory events to cellular phenotypes.
Biochemical and Allosteric Regulation Studies
Enzyme kinetics and binding assays can elucidate allosteric mechanisms that positively regulate macromolecule metabolism. Morea et al. discuss how allostery modulates enzyme activity, which is crucial for understanding metabolic control. These methods complement genetic approaches.
How CRISPR Can Be Used to Study GO:0010604 positive regulation of macromolecule metabolic process
Knockout
CRISPR knockout (KO) generates loss-of-function mutations by introducing frameshifts or deletions in a target gene. This is used to determine whether a gene is necessary for positive regulation of macromolecule metabolic processes. For example, knocking out MTOR in ependymal cells would test its role in differentiation and macromolecule metabolism.
Point Mutation
CRISPR point mutation introduces specific nucleotide changes to model disease-associated variants or to abrogate catalytic activity. This allows precise interrogation of regulatory domains, such as kinase-dead mutants of MTOR, to dissect signaling pathways.
Knock-in
CRISPR knock-in inserts exogenous sequences, such as fluorescent tags or reporter genes, at a specific locus. Tagging endogenous proteins enables real-time tracking of macromolecule metabolism components, as demonstrated for S100A proteins in glioblastoma.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression increases gene expression above endogenous levels. This is useful to test sufficiency, e.g., whether overexpressing a candidate gene enhances macromolecule metabolic processes. Such approaches complement KO studies.
How EDITGENE Supports positive regulation of macromolecule metabolic process Research
Researchers studying positive regulation of macromolecule metabolic process-related genes often need to determine whether a candidate gene is causally involved in upregulating macromolecule metabolism. This requires precise genetic manipulation, which can be achieved through CRISPR-based models. EDITGENE provides a comprehensive suite of services to support such investigations.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of macromolecule metabolic process research.
Frequently Asked Questions About positive regulation of macromolecule metabolic process
What is GO:0010604?
GO:0010604 is the Gene Ontology term for positive regulation of macromolecule metabolic process, defined as any process that increases the frequency, rate or extent of chemical reactions and pathways involving macromolecules.
What genes are involved in positive regulation of macromolecule metabolic process?
Key genes include MTOR, AMBRA1, S100A proteins, and matricellular proteins, among others.
How is macromolecule metabolic process regulated?
It is regulated by signaling pathways such as mTOR, which integrates nutrient and growth factor signals to promote anabolism and inhibit catabolism.
What diseases are associated with dysregulated macromolecule metabolism?
Diseases include sarcopenia, atherosclerosis, diabetic nephropathy, and cancer.
What methods are used to study positive regulation of macromolecule metabolism?
Common methods include RNA-seq, Ribo-seq, proteomics, metabolomics, and CRISPR screening.
How can CRISPR help study this process?
CRISPR enables knockout, point mutation, knock-in, and overexpression models to test gene function in macromolecule metabolism.
What is the role of mTOR in macromolecule metabolism?
mTOR positively regulates translation and ribosome biogenesis while inhibiting autophagy, thus promoting macromolecule synthesis.
Is autophagy part of macromolecule metabolic process?
Yes, autophagy is a degradation pathway for macromolecules and is positively regulated by AMBRA1.
What is the connection between macromolecule metabolism and aging?
Metabolic analysis in C. elegans identified positive modulators of longevity and healthspan, linking macromolecule metabolism to aging.
How does allostery regulate macromolecule metabolism?
Allosteric regulation modulates enzyme activity, providing rapid control of metabolic flux.
Conclusion
GO:0010604, positive regulation of macromolecule metabolic process, is a fundamental biological process that coordinates the synthesis, modification, and degradation of macromolecules. Its dysregulation underlies numerous diseases, making it a key area of research. By leveraging CRISPR-based models and advanced omics technologies, researchers can dissect the regulatory networks and identify therapeutic targets. EDITGENE provides the tools and expertise to accelerate these discoveries.
References
- 1. Jonk SM et al.. 2025. Metabolic analysis of sarcopenic muscle identifies positive modulators of longevity and healthspan in C. elegans.. Redox Biol 85:103732 PMID: 40544604
- 2. Brązert M et al.. 2020. New markers for regulation of transcription and macromolecule metabolic process in porcine oocytes during in vitro maturation.. Mol Med Rep 21(3):1537-1551 PMID: 32016446
- 3. Morea V et al.. 2024. Is allostery a fuzzy concept?. FEBS Open Bio 14(7):1040-1056 PMID: 38783588
- 4. Pervaiz N et al.. 2023. Matricellular proteins in atherosclerosis development.. Matrix Biol 120:1-23 PMID: 37086928
- 5. Antonioli M et al.. 2015. AMBRA1-regulated autophagy in vertebrate development.. Int J Dev Biol 59(1-3):109-17 PMID: 26374532
- 6. Cómitre-Mariano B et al.. 2025. S100A proteins show a spatial distribution of inflammation associated with the glioblastoma microenvironment architecture.. Theranostics 15(2):726-744 PMID: 39744679
- 7. Bankolé A et al.. 2025. mTOR controls ependymal cell differentiation by targeting the alternative cell cycle and centrosomal proteins.. EMBO Rep 26(12):3075-3105 PMID: 40307619
- 8. Raptis AE et al.. 2001. Pathogenesis of diabetic nephropathy.. Exp Clin Endocrinol Diabetes 109 Suppl 2:S424-37 PMID: 11460589
